HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color
Open Access
- 9 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 10 (4) , 1542-1548
Abstract
Purpose: Black and Latinx MSM and transgender POC disproportionately experience new HIV diagnoses. Determining effective HIV prevention methods requires the inclusion of these communities in research and thorough post-trial experience evaluations. This study sought to evaluate the experiences of Black and Latinx MSM and transgender POC in HIV prevention research and identify facilitators and barriers to continued trials participation. Methods: A survey was developed in partnership with the community engagement team based on emerging themes during research participant check-ins with the team. The survey was built in REDCap and distributed to participants via text message. The survey assessed experiences with the research process time commitments, study responsibilities, compensation, experiences with Truvada®, characteristics of the research study team and site, barriers to continued study participation, willingness to participate in future studies, and overall satisfaction. All statistical analysis was completed in Stata. Results: Forty-four participants were enrolled in the study. Most participants (98%) were satisfied with their experiences in HIV prevention research. Job or school schedules were the most frequently cited barrier to study participation while Truvada® provision and adequate study visit compensation, length, number, and frequency were facilitators. Participants reported that research staff made them feel comfortable when talking about sexual behaviors, alcohol use, mental health, drug use, housing problems, violence in relationships, and legal problems. Conclusions: Evaluating the experiences of key communities in HIV prevention research can help identify barriers and facilitators to clinical trials engagement and improve the design of future trials.Keywords
This publication has 23 references indexed in Scilit:
- Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with MenArchives of Sexual Behavior, 2017
- Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York CityPLOS ONE, 2017
- Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials ResearchJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Who's Willing? Characteristics Associated with Willingness to Participate in Clinical Research.2016
- ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender womenGlobal Public Health, 2016
- Minorities Remain Underrepresented in HIV/AIDS Research Despite Access to Clinical TrialsHIV Research & Clinical Practice, 2014
- Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical TrialsPrevention Science, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Enrollment of Racial/Ethnic Minorities in NIAID-Funded Networks of HIV Vaccine Trials in the United States, 1988 to 2002Public Health Reports®, 2005
- REVIEW OF COMMUNITY-BASED RESEARCH: Assessing Partnership Approaches to Improve Public HealthAnnual Review of Public Health, 1998